Literature DB >> 8163648

Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.

J P Liu1, I J Clarke, J W Funder, D Engler.   

Abstract

Studies were performed to determine the effects of intracerebroventricular norepinephrine (NE) or neuropeptide Y (NPY) on the ovine hypothalamic-pituitary-adrenal (HPA) axis. NE (50 micrograms) increased mean hypophysial-portal corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) levels (1 h, 1.3- and 2.9-fold; 4 h, 2.2- and 5.7-fold) and caused acute and sustained increases in mean plasma ACTH and cortisol. NPY (50 microgram) also increased mean CRF and AVP levels (1 h, 1.4- and 4.2-fold; 4 h, 1.1- and 1.9-fold), increased pituitary-adrenal activity at 1 h, and caused ACTH hypersecretion at 4 h. When added to cultured ovine anterior pituitary cells, NPY neither increased basal ACTH release nor augmented CRF- or AVP-induced ACTH release. We conclude that: (a) activation of either the central noradrenergic or NPY pathways causes an acute and sustained stimulation of the ovine HPA axis; (b) such activation increases the AVP/CRF ratio, suggesting a dominant role for AVP in the ovine stress response; and (c) the central noradrenergic or NPY systems may cause sustained HPA activation by attenuating or disrupting the glucocorticoid negative feedback on those brain areas concerned with regulation of the HPA axis. The possible roles of the central noradrenergic and NPY systems in the etiology of the hypercortisolemia of endogenous depression and anorexia nervosa are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163648      PMCID: PMC294157          DOI: 10.1172/JCI117121

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  73 in total

1.  Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams.

Authors:  A Caraty; M Grino; A Locatelli; V Guillaume; F Boudouresque; B Conte-Devolx; C Oliver
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 2.  Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor.

Authors:  F A Antoni
Journal:  Endocr Rev       Date:  1986-11       Impact factor: 19.871

3.  Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.

Authors:  W H Kaye; W Berrettini; H Gwirtsman; D T George
Journal:  Arch Gen Psychiatry       Date:  1990-06

4.  Glucoresponsive neurons in rat ventromedial hypothalamic tissue slices in vitro.

Authors:  T Ono; H Nishino; M Fukuda; K Sasaki; K Muramoto; Y Oomura
Journal:  Brain Res       Date:  1982-01-28       Impact factor: 3.252

Review 5.  Hypercortisolism and its possible neural bases.

Authors:  R M Sapolsky; P M Plotsky
Journal:  Biol Psychiatry       Date:  1990-05-01       Impact factor: 13.382

6.  Second messengers involved in the regulation of corticotropin-releasing hormone mRNA and peptide in cultured rat fetal hypothalamic primary cultures.

Authors:  R L Emanuel; D M Girard; D L Thull; J A Majzoub
Journal:  Endocrinology       Date:  1990-06       Impact factor: 4.736

7.  Relationships between brain noradrenergic activity and blood glucose.

Authors:  G A Smythe; H S Grunstein; J E Bradshaw; M V Nicholson; P J Compton
Journal:  Nature       Date:  1984 Mar 1-7       Impact factor: 49.962

Review 8.  Corticosteroid inhibition of ACTH secretion.

Authors:  M E Keller-Wood; M F Dallman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

9.  Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat.

Authors:  B J Everitt; T Hökfelt; L Terenius; K Tatemoto; V Mutt; M Goldstein
Journal:  Neuroscience       Date:  1984-02       Impact factor: 3.590

10.  Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: a marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin.

Authors:  F A Antoni; G Fink; W J Sheward
Journal:  J Endocrinol       Date:  1990-05       Impact factor: 4.286

View more
  7 in total

1.  Organization and Integration of the Endocrine System.

Authors:  George P Chrousos
Journal:  Sleep Med Clin       Date:  2007-06

Review 2.  Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin.

Authors:  Timothy G Dinan; Lucinda V Scott
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

3.  Regulation of Pulsatile and Entropic ACTH Secretion Under Fixed Exogenous Secretagogue Clamps.

Authors:  Ferdinand Roelfsema; Paul Aoun; Paul Y Takahashi; Dana Erickson; Rebecca Yang; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

4.  Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia.

Authors:  A Sainsbury; F Rohner-Jeanrenaud; I Cusin; K E Zakrzewska; P A Halban; R C Gaillard; B Jeanrenaud
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

Review 5.  Gestational Hypoxia and Developmental Plasticity.

Authors:  Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 6.  Constitutional thinness and anorexia nervosa: a possible misdiagnosis?

Authors:  Bruno Estour; Bogdan Galusca; Natacha Germain
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-20       Impact factor: 5.555

Review 7.  Complementary Role of Oxytocin and Vasopressin in Cardiovascular Regulation.

Authors:  Ewa Szczepanska-Sadowska; Agnieszka Wsol; Agnieszka Cudnoch-Jedrzejewska; Tymoteusz Żera
Journal:  Int J Mol Sci       Date:  2021-10-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.